Ipek Bulut
Istanbul, Turkey
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Nicotinamide N-methyltransferase as a therapeutic target in taxane-resistant castration-resistant prostate cancer.
Journal: Cell death discovery
Published: September 25, 2025
Menin-driven mTOR signaling sustains taxane resistance in CRPC and reveals a targetable vulnerability for combination therapy.
Journal: Cell communication and signaling : CCS
Published: July 15, 2025
Identification of epigenetic monotherapy candidates in taxane-resistant CRPC.
Journal: Turkish journal of biology = Turk biyoloji dergisi
Published: May 14, 2025
Butyrylcholinesterase (BChE) downregulation in taxane resistance: implications for prostate cancer.
Journal: Turkish journal of biology = Turk biyoloji dergisi
Published: February 24, 2025
Exploiting epigenetic targets to overcome taxane resistance in prostate cancer.
Journal: Cell death & disease
Published: September 13, 2023
Epigenetic-focused CRISPR/Cas9 screen identifies (absent, small, or homeotic)2-like protein (ASH2L) as a regulator of glioblastoma cell survival.
Journal: Cell communication and signaling : CCS
Published: May 02, 2023
Promising anticancer agents based on 8-hydroxyquinoline hydrazone copper(II) complexes.
Journal: Frontiers in chemistry
Published: November 23, 2022
Dual LSD1 and HDAC6 Inhibition Induces Doxorubicin Sensitivity in Acute Myeloid Leukemia Cells.
Journal: Cancers
Published: June 27, 2022
Solution chemical properties and anticancer potential of 8-hydroxyquinoline hydrazones and their oxidovanadium(IV) complexes.
Journal: Journal of inorganic biochemistry
Published: May 20, 2022
Showing 1-10 of 10
Last Updated: 09/26/2026